These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8725708

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B, Svensson PJ, He X, Dahlbäck B.
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [Abstract] [Full Text] [Related]

  • 6. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA, Thomassen MC, van Oerle R, Hamulyak K, Hemker HC, Tans G, Rosing J.
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [Abstract] [Full Text] [Related]

  • 7. Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.
    Simioni P, Scarano L, Gavasso S, Sardella C, Girolami B, Scudeller A, Girolami A.
    Br J Haematol; 1996 Feb; 92(2):435-41. PubMed ID: 8603014
    [Abstract] [Full Text] [Related]

  • 8. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J.
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [Abstract] [Full Text] [Related]

  • 9. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
    Tans G, Nicolaes GA, Rosing J.
    Semin Hematol; 1997 Jul; 34(3):244-55. PubMed ID: 9241709
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB, Sturk A.
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [Abstract] [Full Text] [Related]

  • 12. Association of elevated levels of prothrombin fragment 1+2 and Arg506 to Gln mutation in patients with a history of ischemic stroke.
    De Lucia D, Papa ML, Ammendola F, Pezzella S, Del Giudice V, Marotta R, Renis V, Di Mauro C, Maisto G, Masi S, Nina P, Franco A, Schisano G.
    J Neurosurg Sci; 1999 Mar; 43(1):45-50; discussion 50-1. PubMed ID: 10494665
    [Abstract] [Full Text] [Related]

  • 13. Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables.
    Lowe GD, Rumley A, Woodward M, Reid E, Rumley J.
    Thromb Haemost; 1999 Jun; 81(6):918-24. PubMed ID: 10404768
    [Abstract] [Full Text] [Related]

  • 14. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R, Jennersjö C, Lindahl TL.
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G, Valverde S.
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [Abstract] [Full Text] [Related]

  • 16. Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients.
    Montes MA, Fox EA, Longtine JA, Dorfman DM.
    Arch Pathol Lab Med; 1998 Apr; 122(4):325-9. PubMed ID: 9648899
    [Abstract] [Full Text] [Related]

  • 17. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ, Benoni G, Fredin H, Björgell O, Nilsson P, Hedlund U, Nylander G, Bergqvist D, Dahlbäck B.
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [Abstract] [Full Text] [Related]

  • 18. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B.
    J Intern Med Suppl; 1997 Sep; 740():1-8. PubMed ID: 9350175
    [Abstract] [Full Text] [Related]

  • 19. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M, Kyrle PA, Eichinger S, Rintelen C, Mannhalter C, Pabinger I.
    Wien Klin Wochenschr; 1996 Sep; 108(19):607-10. PubMed ID: 8921576
    [Abstract] [Full Text] [Related]

  • 20. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C.
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.